Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma
Lucas D. Caeiro(University of Miami), Lluís Morey(University of Miami), Ramiro E. Verdún(University of Miami), Ho Lam Chan(University of Miami), Carolina P. Bañuelos(University of Miami), Simone Sidoli(Albert Einstein College of Medicine), J A Brabson(University of Miami), Stephanie Stransky(Albert Einstein College of Medicine), Liliana Garcia-Martinez(Sylvester Comprehensive Cancer Center), Peter W. Lewis(University of Wisconsin System), Diana Domínguez(Institute for Research in Biomedicine), Tong Liu(Jianghan University), Zheng Wang(Shandong Provincial Hospital), Yusheng Zhang(University of Miami), Mengsheng Zha(University of Miami), Rodrigo L. Borges(Sylvester Comprehensive Cancer Center), Salvador Aznar Benitah(Institute for Biomedicine), Daniel Bilbao(University of Miami), Yuichiro Nakata(University of Miami), Luisa Cimmino(Howard Hughes Medical Institute)
Cited by 8
Related Papers
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|659
Epigenetic mechanisms in breast cancer therapy and resistance
|Nature Communications|2021|457
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
|Cancer Cell|2016|200